Repro Med Systems, Inc. (KRMD) News
Filter KRMD News Items
KRMD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest KRMD News From Around the Web
Below are the latest news stories about KORU MEDICAL SYSTEMS INC that investors may wish to consider to help them evaluate KRMD as an investment opportunity.
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare ConferenceMAHWAH, N.J., November 29, 2023--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in Piper Sandler’s 35th Annual Healthcare Conference on November 29, 2023. |
KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023MAHWAH, N.J., November 28, 2023--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced it will host an investor day at the Mahwah, NJ headquarters on Tuesday, December 5, 2023, from 10:00 a.m. to 12:00 p.m. Eastern Time. The event will include |
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call TranscriptKORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call Transcript November 8, 2023 KORU Medical Systems, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.04. Operator: Good day. And welcome to the KORU Medical Systems Third Quarter 2023 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note this conference […] |
The past three years for KORU Medical Systems (NASDAQ:KRMD) investors has not been profitableFor many investors, the main point of stock picking is to generate higher returns than the overall market. But in any... |
KORU Medical Systems Inc (KRMD) Reports Q3 2023 Financial Results and Updates Full Year OutlookChallenges in Novel Therapies and Domestic Core Markets Lead to Revised Full Year Guidance |
KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion SystemMAHWAH, N.J., November 08, 2023--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced a development agreement with a biopharmaceutical manufacturer for KORU Medical to develop and seek regulatory approval for a next-generation infusion system |
KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial OfficerMAHWAH, N.J., November 08, 2023--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced the appointment of Ken Miller as Chief Commercial Officer, effective November 6, 2023. |
KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 OutlookMAHWAH, N.J., November 08, 2023--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the third quarter ended September 30, 2023 and updates full year 2023 outlook. |
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled SyringesMAHWAH, N.J., November 07, 2023--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced that it received U.S. Food and Drug Administration (FDA) clearance for use of the FREEDOM60® Infusion System with Hizentra® 50 mL prefilled syringes (PFS). |
KORU Medical Systems to Participate in Upcoming Investor ConferencesMAHWAH, N.J., November 02, 2023--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in two upcoming investor conferences. |